Centene Corporation CNC

Q3 FY2026 · ended Sep 30, 2026 · Revenue $45.10B, +0.5% YoY · Filed Oct 27, 2026

Centene Corporation (CNC) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $45.1 billion and a net loss of $71.0 million. Free cash flow was -$3.9 billion. As of Sep 30, 2026 it held $38.4 billion in cash and investments and $15.5 billion in total debt.

Revenue
$45.10B
+0.5% vs year-ago quarter
Net income
$-71.00M
+98.9% vs year-ago quarter
Operating cash flow
$-3.67B
-370.6% vs year-ago quarter
Free cash flow
$-3.86B
-437.4% vs year-ago quarter
EPS
$-0.14
+99.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
495.07M
+0.7% vs year-ago quarter
Net cash
$22.84B
Q3 FY2026
Operating margin
0.6%
TTM

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
CNC (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
St Louis, MO
SEC filer status
Large accelerated filer
SEC CIK
1071739

Other Hospital & Medical Service Plans companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Revenue
$45.1B
$44.4B
$44.7B
$44.7B
$44.9B
Operating income
-$307.0M
$1.2B
$1.9B
-$1.7B
-$7.0B
Net income
-$71.0M
$1.1B
$1.5B
-$1.1B
-$6.6B
Diluted EPS
-$0.14
$2.19
$3.11
-$2.24
-$13.50
Operating cash flow
-$3.7B
$3.6B
$4.4B
$437.0M
$1.4B
Free cash flow
-$3.9B
$3.4B
$4.2B
$224.0M
$1.1B
Total assets
$79.3B
$83.0B
$81.2B
$76.7B
$82.1B
Total liabilities
$57.0B
$60.4B
$59.6B
$56.7B
$61.0B
Stockholders' equity
$22.2B
$22.6B
$21.4B
$20.0B
$20.9B
Cash and investments
$38.4B
$43.4B
$40.3B
$37.4B
$37.4B
Total debt
$15.5B
$16.1B
$16.4B
$18.3B
$17.6B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Oct 27, 2026 Oct 27, 2026
10-Q Quarterly report Oct 27, 2026 Sep 30, 2026
8-K Current report
Other events
Oct 8, 2026 Oct 8, 2026
8-K Current report
Regulation FD disclosure
Sep 16, 2026 Sep 16, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 17, 2026 Aug 12, 2026
8-K Current report
Other events
Jul 29, 2026 Jul 29, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.